Approaches to Improve Efficiency of Dendritic Cell-based Therapy of High Grade Gliomas

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|37|5738-5751

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.37, 2016-11, pp. : 5738-5751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic cell-based approaches to cancer immunotherapy

By Morse M.A.   Lyerly H.K.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 10, 1998-10 ,pp. : 1617-1627

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic Therapy for High-Grade Gliomas

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 184-194

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy and Target Therapy in the Management of Adult High- Grade Gliomas

By  

Current Cancer Drug Targets, Vol. 12, Iss. 8, 2012-10 ,pp. : 1016-1031

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cell-Based Therapy as a Multidisciplinary Approach to Cancer Treatment: Present Limitations and Future Scopes

By  

Current Medicinal Chemistry, Vol. 13, Iss. 26, 2006-11 ,pp. : 3113-3119

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cell-Based Therapies in the Bench and the Bedsides

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 305-310

Bentham Science Publishers

Access to resources Recommend Favorite